← SynDRA
quinagolide
SynDRA canonical compound SYN0041619 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | DRD2 | PRL |
|---|
| Mechanism of action | dopamine receptor agonist |
|---|
| Indication | hyperprolactinemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
- DRD2
- Adra1a
- Htr2a
- Htr7
- Htr6
- Htr5b
- Htr5a
- Htr4
- Htr3b
- Htr3a
- Htr2c
- Htr2b
Mechanisms of action (all sources)
- dopamine receptor agonist
Drug classes
- Dopamine Agents
- Dopamine Agonists
- Neurotransmitter Agents
ATC classes
Cross-references
Synonyms
- norprolac
- Quinagolide (hydrochloride)
- Norprolac
- CV205-502 hydrochloride
- Norprolac (TN)
- SCHEMBL677709
- orb1708766
- Quinagolide hydrochloride (BAN)
- EBC-90141
- HY-13736A
- AKOS040736005
- CS-5136
- FQ27369
- SDZ-205502
- DA-57305
- MS-27702
- CV-205502
- D08457
- F85304
- T12605
- Quinagolidum
- CV 205-502
- CV205-502
- RefChem:871915
- G02CB04
- Quinagolida
- Norprolac;SDZ 205-502;CV 205-502
- Quinagolide (INN/BAN)
- SCHEMBL143485
- orb1740997
- CHEBI:135627
- BDBM50225362
- EBC-26932
- NCGC00522534-01
- CS-0007763
- NS00069177
- D07217
- T68483
Look up quinagolide in the interactive SynDRA portal →